Literature DB >> 8762075

Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.

A T Najbar1, C G Li, M J Rand.   

Abstract

1. The effects of the P2-purinoceptor agonists, adenosine 5'-triphosphate (ATP), alpha, beta-methylene ATP (alpha, beta-MeATP), beta, gamma-methylene ATP (beta, gamma-MeATP), L-beta, gamma-methylene ATP (L-beta, gamma-MeATP), adenosine-5'-O-(2-thiodiphosphate) (ADP beta S), and 2-methylthio ATP (2-MeSATP) were investigated on the isometric tension of the rat anococcygeus muscle. 2. Non-cumulative additions of ATP (100-1500 microM), alpha, beta-MeATP (1-300 microM), beta, gamma-MeATP (10-300 microM), L-beta, gamma-MeATP (3-100 microM) and ADP beta S (1-100 microM) produced concentration-dependent contractions, whereas 2-MeSATP (1-100 microM) had no effect. The rank order of potency was alpha, beta-MeATP > L-beta, gamma-MeATP > or = ADP beta S > beta, gamma-MeATP > > ATP > 2-MeSATP. 3. Contractions to cumulative additions of ATP, alpha, beta-MeATP, beta, gamma-MeATP and L-beta, gamma-MeATP were subject to desensitization whilst those to ADP beta S were unaffected. 4. Contractions to ATP, alpha, beta-MeATP, beta, gamma-MeATP and ADP beta S were abolished by the non-selective P2X/. P2Y-purinoceptor antagonist, suramin (100 microM). In contrast, contractions to ATP, alpha, beta-MeATP and beta, gamma-MeATP were not affected by the non-selective P1-purinoceptor antagonist 8-(p-sulphophenyl)-theophylline (8SPT, 30 microM). Blockade of P2X-purinoceptors with the selective P2X-purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, 10 microM) or desensitization with L-beta, gamma-MeATP (10 microM) abolished contractions to alpha, beta-MeATP, but enhanced those to ADP beta S. The P2Y-purinoceptor antagonist, reactive blue 2 (RB2, 100 microM) enhanced contractions to ATP and alpha, beta-MeATP but abolished those to ADP beta S. 5. Simultaneous addition of alpha, beta-MeATP and ADP beta S produced an additive contraction. 6. The findings suggest that in the rat anococcygeus, smooth muscle cells are endowed with two distinct P2-purinoceptors which subserve contractions: a P2X-purinoceptor activated by ATP and its analogues, and another type of P2-purinoceptor activated by ADP beta S.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762075      PMCID: PMC1909706          DOI: 10.1111/j.1476-5381.1996.tb15435.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.

Authors:  G Lambrecht; T Friebe; U Grimm; U Windscheif; E Bungardt; C Hildebrandt; H G Bäumert; G Spatz-Kümbel; E Mutschler
Journal:  Eur J Pharmacol       Date:  1992-07-07       Impact factor: 4.432

2.  Ca(2+)-stores mobilization by diadenosine tetraphosphate, Ap4A, through a putative P2Y purinoceptor in adrenal chromaffin cells.

Authors:  E Castro; J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.

Authors:  P Leff; B E Wood; S E O'Connor
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 4.  P1- and P2-purinoceptor subtypes--an update.

Authors:  C Kennedy
Journal:  Arch Int Pharmacodyn Ther       Date:  1990 Jan-Feb

5.  Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.

Authors:  P M Dunn; A G Blakeley
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

6.  ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor.

Authors:  L A Welford; N J Cusack; S M Hourani
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

Review 7.  How should P2X purinoceptors be classified pharmacologically?

Authors:  C Kennedy; P Leff
Journal:  Trends Pharmacol Sci       Date:  1995-05       Impact factor: 14.819

8.  P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens.

Authors:  R Bültmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

9.  Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.

Authors:  J Pintor; M A Díaz-Rey; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

10.  Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.

Authors:  C H Hoyle; G E Knight; G Burnstock
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

View more
  2 in total

1.  Coupling of a P2Z-like purinoceptor to a fatty acid-activated K(+) channel in toad gastric smooth muscle cells.

Authors:  H Zou; M Ugur; R M Drummond; J J Singer
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

2.  Evidence that ATP or a related purine is an excitatory neurotransmitter in the longitudinal muscle of mouse distal colon.

Authors:  M G Zizzo; F Mulè; R Serio
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.